COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections.
Quick Facts
What This Study Found
Thymosin alpha1 may serve as a therapeutic agent for lung infections by balancing immune responses.
Key Numbers
How They Did This
This is a review article that synthesizes recent findings on thymosin alpha1 and its role in immune regulation during lung infections.
Why This Research Matters
Understanding how thymosin alpha1 works could lead to new therapies for lung infections, which remain a significant health threat. This research could improve patient outcomes in future respiratory outbreaks.
What This Study Doesn't Tell Us
As a review, it does not present original experimental data and relies on existing literature, which may vary in quality.
Trust & Context
- Original Title:
- COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections.
- Published In:
- International immunopharmacology, 117, 109949 (2023)
- Authors:
- Bellet, Marina M(4), Renga, Giorgia(4), Pariano, Marilena(4), Stincardini, Claudia, D'Onofrio, Fiorella, Goldstein, Allan L, Garaci, Enrico, Romani, Luigina, Costantini, Claudio
- Database ID:
- RPEP-06729
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06729APA
Bellet, Marina M; Renga, Giorgia; Pariano, Marilena; Stincardini, Claudia; D'Onofrio, Fiorella; Goldstein, Allan L; Garaci, Enrico; Romani, Luigina; Costantini, Claudio. (2023). COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections.. International immunopharmacology, 117, 109949. https://doi.org/10.1016/j.intimp.2023.109949
MLA
Bellet, Marina M, et al. "COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections.." International immunopharmacology, 2023. https://doi.org/10.1016/j.intimp.2023.109949
RethinkPeptides
RethinkPeptides Research Database. "COVID-19 and beyond: Reassessing the role of thymosin alpha1..." RPEP-06729. Retrieved from https://rethinkpeptides.com/research/bellet-2023-covid19-and-beyond-reassessing
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.